Medical Tourism Market Trends and Growth Research by Treatment Type (Orthopedic/Spine Treatments, Oncology/Cancer Treatments, Cosmetic Treatments, Cardiovascular Treatments, Dental Treatments, Fertility/IVF Treatments, others), by Regions - Global Forecast Till 2023
get free sample copy @ https://www.marketresearchfuture.com/sample_request/1975 Market Insights Increasing costs of treatments for chronic diseases and other kinds of treatment have been highly encouraging of medical tourism. It has been a common practice in an effort to procure good treatment at lower costs. Developing economies around the world offer high-quality medical treatments which attract patients from other parts of the world. Market Research Future has published its newest report on the global medical tourism market which reveals an expected and promising CAGR of 21.4% during the forecast period from 2017 to 2023. The market was found to be valued at USD 70,836.9 Mn at the start of the forecast period and is likely to grow to reach an impressive USD 226,762.7 Mn by the end of 2023. Market Segmentation The global medical tourism market size by country is segmented on the basis of type. This is divided into neurology/neurosurgery treatments, orthopedic/spine treatments, fertility/IVF treatments, cosmetic treatments, cardiovascular/cardiology treatments, oncology/cancer treatments, and dental treatments. Among these, The cosmetic treatments market is the most lucrative segment with a high demand for facial rejuvenation and breast reconstruction treatments. The cost-efficient prices at medical tourism destinations for cosmetic procedures drive the segment's growth. Regional Analysis The Asia Pacific, due to a high concentration of developing economies has a 43.7% share of the market making it the market leader by regional assessment. Investments in technological advancements and state of the art medical machinery are augmenting market growth. Moreover, The region includes South Korea which is a highly popular destination for cosmetic procedures. The APAC is expected to grow at a highly promising CAGR of 22% during the forecast period. Eastern and Central Europe also represent an important regional segment which is growing rapidly and is expected to establish itself as a medical tourism destination over the forecast period. Key Players Noted market players that are included in the report are Asklepios Kliniken Verwaltungsgesellschaft mbH, Shouldice Hospital, Bangkok Hospital, Bumrungrad International Hospital, Samitivej PCL, CHRISTUS MUGUERZA, Clemenceau Medical Center, Anadolu Medical Center, Prince Court Medical Centre, Fortis Healthcare, Gleneagles Global Hospitals Group, and Schoen-Kliniken. These market players are extensively profiled in MRFR's competitive analysis. Access Report @ https://www.marketresearchfuture.com/reports/medical-tourism-market-1975 About Market Research Future: MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
0 Comments
Population Health Management Market Growth Overview Analysis Statistics 2020 by Key Driving Factor5/31/2020 Population Health Management Market Information: Component (Hardware and Others), Solution (Data Integration & Management, Analytics, and Others), Delivery Mode (On-Premise and Others), End-User (Healthcare Providers, Others) –Global Forecast Till 2023
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/3123 Global Population Health Management Market - Overview Population health management is the aggregation and analysis of patient data across multiple health domains and data resources, so as to improve both clinical and financial outcomes. The explosive growth of healthcare data availability which includes clinical data, market data etc. is creating a new set of opportunities and challenges for healthcare industry. The global population health management market is growing with the rapid pace; mainly due to the technological innovation. According to a recent study report published by the Market Research Future, the global population health management is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2023). Global Population Health Management Market - Competitive Analysis The global population health management market growth is currently dominated by few players. IBM is one of them by holding a strong share in the market. IBM is a U.S. based company that manufactures and markets computer hardware and software and offers hosting and consulting services in areas ranging from mainframe computers to nanotechnology. The prime emphasis of the company is on digital revolution by improving data, cloud, and mobile and social security. The company has entered various collaboration to expand their product portfolio and market share. For instance, on 11 Oct 2016, IBM entered a global strategic alliance with Siemens Healthineers in Population Health Management (PHM). The main aim of this alliance is to help health systems to deliver value-based care to patients. IBM is also driven by its innovative product, and services. On February 21, 2017, IBM Watson launched new machine learning and artificial intelligence (AI) initiatives with special focus on population health management, advanced imaging analytics, and care coordination. Cerner Corporation is also one of the leading player in population health management market. On April 13, 2015, Cerner Corporation and Qualcomm Life, Inc. teamed up to extend Cerner’s medical device connectivity capabilities beyond the hospital to the home. Global Population Health Management Market - Regional Analysis Most of the existing market players are concentrated in the Americas owing to well-established market and high healthcare expenditures. According to the Centers for Medicare & Medicaid Services, in 2015, U.S. healthcare spending increased 5.8% reaching USD 3.2 trillion Canadian healthcare specifically was stressed by an advancing demographic move. The increase of insurance coverage because of health care reform (Affordable Care Act, 2010) in the U. S. additionally prompted an expansion in health care spending. The regulatory changes in the U.S. such as implementation of Affordable Care Act and Hospital Readmissions Reduction Program coupled with Medicare initiative to penalize unnecessary patient readmissions will strengthen the position of the U.S. Access Report Deatails @ https://www.marketresearchfuture.com/reports/population-health-management-market-3123 About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. Middle East And Africa Pediatric Healthcare Market Share, Application And Growth Analysis, By Type Of Diseases (Short Term Diseases, Chronic Diseases And Others), By Therapeutics (Cardiology, Allergy And Immunology, Gastroenterology, Infectious Disease And Others), By Treatment (Medication, Surgery, And Others) - Forecast To 2023
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2778 Paediatric Healthcare-Overview Paediatrics is a branch of medicine which deals with diagnosis and treatment of diseases related to paediatric group. It can be classified into the four categories namely neonates (from birth till the first 28 days of life), infants (29 days to 2 years), children (2 years to 12 years) and adolescents (12 years to 18 years). Paediatrician is a medical professional who specializes in providing treating the paediatric group. Paediatric medical devices are devices used for the treatment and care of infants and children below 18 years having some healthcare issues. Demand for paediatric medical devices is increasing due to high incidence of chronic illnesses among children, high premature birth rate, increasing birth defects among new born, and rising awareness regarding disease conditions among children. Malnutrition among children prevalent in under developed parts of the world is also a major driver of this market. Global Paediatric medical device market is expected to grow at a CAGR of 10.5% during forecast period 2017 to 2023. Key players in the Paediatric Healthcare: Hoffmann-La Roche AG (Germany), Medtronic Plc. (U.S.), Bayer AG (Germany), Abbott (U.S.), I-SENS, Inc. (South Korea), Siemens (U.S.) and others. The main focus of these players is tapping the market in developing regions across the globe. Also product differentiation plays an important role for sustaining the growth of key players in the Pediatric Healthcare Market challenges Middle East & Africa Paediatric Healthcare Market-Regional Analysis: Healthcare system in the Middle East & Africa has exhibited tremendously growth from last few years. In the Middle East, the market is expected to grow at a fastest rate owing to the development of healthcare system as well as rising important of diagnosis and treatment of diseases. Furthermore, increasing support by the government authorities for development of novel therapies also influences the growth of the market. In the Middle East & Africa, United Arab Emirates is the largest market for paediatric healthcare market. In Africa, there is tremendous demand for paediatric medical devices owing to an increasing health problems among the infants and children. There is wide scope of the growth of paediatric medical devices and nutritional products in number of under developed countries in African region. Number of government organisation are engaged in the evaluation of healthcare conditions in Africa as well as healthcare firms undertake products such as healthcare camps for women and children in this. Report Details @ https://www.marketresearchfuture.com/reports/pediatric-healthcare-market-2778 About Market Research Future At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services kinesio tape market manufacturer Devices Analysis Global Industry Size, Share, Emerging Trends5/31/2020 Global anti-epilepsy drugs market Information, Types of seizures (Generalized seizures and Partial-onset seizures), By Generation (First, second and third) - Forecast to 2022
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2345 Global Anti-epilepsy Drugs Market - Overview Epilepsy is a chronic disorder that causes unprovoked and recurrent seizures. Epilepsy is the fourth most common neurological disorder and affects people of all ages. The patients are reported to loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Increasing prevalence of the epilepsy, rising per capita healthcare expenditure and increasing R&D for the therapeutic procedures of the disease drives the market growth during the forecast period, 2017-2022. According to the World Health Organization in 2017, approximately 50 million people across the globe have epilepsy, making it one of the most common neurological diseases globally. Moreover, it was estimated that nearly 80% of the people with epilepsy live in low- and middle-income countries. Additionally, approval of several late-stage pipeline molecules, advancements in drugs modification and favourable government initiative fuels the market growth. However, side effects related to the therapeutic drugs, increasing generic competition and patent expirations are some of the restrains that for the growth during the forecast period. Global Anti-Epilepsy Drugs Market - Competitive Analysis Characterized by the presence of several well-established and small players, the anti-epilepsy drugs market sales appears to be highly competitive and fragmented. International players who are increasingly expanding their footprint in the developing economy, making it difficult for regional vendors to compete with them, especially in terms of features such as product differentiation, product portfolios, quality, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. The intense competition prevalent in the market dictates the consolidation among marketers. Global Anti-epilepsy Drugs Market - Regional Analysis On the regional backgrounds the Americas leads the global market for anti-epilepsy drugs owing to a well-developed healthcare sector, increasing prevalence of epilepsy and presence of the developed technologies within the region. According to the Centres for Disease Control and Prevention, in 2015, 1.2% of the total U.S. population had active epilepsy. Moreover, it was estimated that the yearly total direct and indirect cost of epilepsy in the U.S. was about USD 15.5 billion. Europe is second in the market due to rising healthcare expenditures, huge patient population and growing healthcare R&D expenses by the government. The Asia Pacific region is the fastest growing region due to the developing economies like India and China which are increasing their healthcare expenditures and have huge patient population. Moreover, favourable government policies within the region fuels the market growth. Middle East and Africa have the least market share, especially due to the presence of poor economies and stringent government policies within the African region. Report Details @ https://www.marketresearchfuture.com/reports/anti-epilepsy-drugs-market-2345 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Microscopy Devices Market bt Type Worldwide 2020 -Global Trends, Size and Industrial Growth Analysis5/31/2020 Microscopy Devices Market Share, Trends And Growth Analysis By Type (Optical Microscopes, Electron Microscope, Scanning Probe Microscope (Spm), Others), By Application (Life Science, Material Science, Pathology), By End User (Hospitals & Clinics, Academic & Research Institutes, Diagnostics Centers) - Forecast Till 2022
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2313 Microscopy Devices are garnering a huge prominence, finding a range of applications in Bio-engineering and electronics. Extensive uptake of electron microscopy, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) in electron micrographs methods are driving the market growth. Market Research Future (MRFR) in recently published study asserts that the global Microscopy Devices Market bt type is expected to reach USD ~10.5 Billion in 2022; it has been noted that market is growing at steady pace and is expected to grow at the CAGR of 7.8% during the forecasted period 2016 – 2022. Surpassing its previous growth records in terms of value & volume, the market is expected to gain prominence over the forecasted period. Global Microscopy Device Market – Segments The MRFR analysis is segmented into four key dynamics for the convenience of understanding; By Types : Comprises Optical Microscopes, Electron Microscope, and Scanning Probe Microscope (SPM), among others. By Applications : Life Science, Material Science, Pathology, and Nanotechnology among others. By End-Users : Comprises Hospitals & Clinics, Academic & Research Institutes, and Diagnostics Centers among others. By Regions : North America, Europe, APAC and Rest-of-the-World. Key Players: FEI, Meiji Techno, Nikon Metrology NV, Woodley Equipment Company Ltd, Radical Scientific Equipments Pvt. Ltd, Bruker, Mauna Kea Technologies SA, Icon Analytical Equipment Pvt. Ltd, Olympus Corporation, NIDEK Inc., Sonix, Inc., Konan Medical USA Inc., Carl Zeiss, and Leica Microsystems are some of the prominent players at the forefront of competition in the Global Microscopy Device Market and are profiled in MRFR Analysis. Industry/ Innovation/ Related News November 2017 – Researchers of Germany and Portugal collaboratively developed the first microscope to concurrently monitor movement and neuron activity in zebrafish larvae without interfering with their behavior. To enable wider use in the research community, the neurobehavioral tracking microscope uses off-the-shelf components and is open source. October 2017 – Researchers at Keio University, Japan developed a single-step, laser-based method to produce small, precise hybrid microstructures of silver and flexible silicone that could enable factories to mass-produce customized devices that combine soft materials, like engineered tissue, with hard materials that add functions, like glucose sensing. Access Report @ https://www.marketresearchfuture.com/reports/microscopy-devices-market-2313 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Global Rheumatoid arthritis market Information, by drug type (Nonsteroidal anti-inflammatory drug type (NSAID), Steroids, Biologic agents) by diagnosis (C-Reactive Protein (CRP) Test, CCP, ESR test) by treatment (Synovectomy, Tendon repair, Joint fusion) - Forecast to 2022
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/1658 Global Rheumatoid Arthritis Market - Overview Rheumatoid arthritis is a chronic inflammatory condition that possible can distress more than just the joints. It is found that in some individuals, the disorder also can damage a various parts of body system, including the lungs, skin, eyes, heart and blood vessels. The global rheumatoid arthritis market is expected to grow at a healthy CAGR of ~4% during the forecast period 2017-2022. Global Rheumatoid Arthritis Market - Competitive Analysis Pfizer Inc. (U.S), Eli Lilly and company (U.S), Bristol-Myers Squibb Company (U.S), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Vertex Pharmaceuticals Incorporated (U.S), Sanofi (France), AstraZeneca (U.K) are some of the prominent players at the forefront of competition in the Global Rheumatoid Arthritis Market and are profiled in MRFR Analysis. Characterized by the presence of several well-established and small players, the global rheumatoid arthritis market forecast of rheumatoid arthritis appears to be highly competitive and fragmented. With well-established market in the North America region major companies like Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Vertex Pharmaceuticals Incorporated, and various others have their home in the region and generate maximum market share. These companies have expanded their operating unit in various other emerging regions as well. Moreover the other small and medium scale players are generating revenue from local market. Global Rheumatoid Arthritis Market - Regional Analysis The global market is segmented into the various regions including Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas accounts for the largest market share of about more than ~38 market share due to increasing patient pool visiting professionals due to rheumatoid arthritis and favourable governmental conditions for research and development. According to the study conducted by the Centers for Disease Control and Prevention in March 2017 it was estimated that about 54.4 million U.S. adults suffer from arthritis that is approximately about 25% of its population. Arthritis is the key cause of disability, and causing pain, aching, stiffness, and swelling of the joints. The most common type of arthritis is rheumatoid arthritis & osteoarthritis. According to the same study it is expected that by 2040, 78 million i.e. 26% of the U.S. adults of age 18 years or older are anticipated to have doctor-diagnosed arthritis. Browse Full Report @ https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Global Pacemaker Market Research Report: Information by Implantability (Implantable Pacemakers and External Pacemaker), Technology (Dual-Chamber Pacemakers, Single-Chamber Pacemakers and Biventricular/CRT Pacemakers), Type (MRI Compatible Pacemakers and Conventional Pacemakers), End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025
GET FREE SAMPLE COPY @ https://www.marketresearchfuture.com/sample_request/1587 Global Pacemaker Market - Overview A pacemaker is a small device that is used to regulate your heart rhythm. The global pacemaker market has been evaluated as steadily growing market and it is expected that the market will continue to grow similarly in the near future. Cardiac pacemaker are the artificial heart rhythm management devices which regularize the heartbeats by sending the electrical impulses to the heart. External pacemakers are the temporary pacing devices which are used during the cardiac surgical procedures to maintain the heartbeat rhythms. External pacemakers require a fully furbished clinical facility. On the other hand, implantable pacemakers are placed inside the skin on the left side of the chest of the patient. The normal life of an implantable pacemaker device is said to be 10 years. The average cost of the device is around $10000 in US. But due to the favourable reimbursement policies of the government, it becomes affordable for the people to undergo the implantation procedure leading to the growth of the market. Among the two types implantable and external, implantable cardiac pacemakers are the most preferred pacemakers by the physicians. Market Research Future published a Half-Cooked Research Report on “Global Pacemaker Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022. Global Pacemaker Market - Competitive Analysis July, 2016- BIOTRONIK had received CE approval for its Edora pacemakers and cardiac resynchronization therapy pacemakers. Biotronik is one of the global leader in cardio- and endovascular medical technology, and is headquartered in Berlin, Germany, and represented in over 100 countries. Many patients have used company implants with improved quality, or have been treated with company’s coronary and peripheral vascular intervention products. However, the company was first to develop pacemaker in 1963, moreover the company has engineered many innovations, which includes Magmaris, the first clinically proven bioresorbable magnesium scaffold, Home Monitoring, Pulsar 18- the world's first 4 F compatible stent for treating long lesions, Orsiro, first hybrid drug-eluting stent; and the world's first implantable cardioverter defibrillators and heart failure therapy devices with ProMRI technology Intended Audience
About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Media Sera and Reagents- Cell Culture Market Research Report: By Type (Media, Sera and Reagents), By Applications (Cancer Research, Virology, Toxicity Testing, Vaccine Production, Drug Development and Others), By End Users (Research Laboratories, Academic Institutes, Pathology Labs, Others) - Global Forecast Till 2023
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1170 Global Media Sera and Reagents- Cell Culture Market - Overview The global media sera and reagents- cell culture market is growing mainly due to the rising incidence of chronic diseases. According to a recent study report published by the Market Research Future, The global media sera and reagents- cell culture market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2027, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2027). Cell culture is a technique used to study the behaviour of cells independent of whole organism. In this technique, cells are taken from an animal or plant and grown under favourable artificial conditions. There are basically three types of cell culture procedures i.e. primary cell culture, secondary cell culture, and cell line. There are various types of media, and serums are used in cell culture technique such as protein free media, serum free media, chemically defined media, specialty media, classical media, Stem cell media, and lysogeny broth. Whereas, reagents include albumin, amino acids, attachment factors, growth factors and cytokines, hormones, biological buffers, biological detergents, cell dissociation reagents, cell freezing reagents, cell separation reagents and others. Global Media Sera and Reagents- Cell Culture Market - Competitive Analysis GE Healthcare, Sigma-Aldrich Corporation, BD Biosciences, VWR International, LLC., EMD Millipore, Lonza Biosciences, and Thermo Fisher Scientific, Inc., Hi-media Laboratories, Biowest, Merck KGaA are some of the prominent players at the forefront of competition in the media sera and reagents- cell culture market and are profiled in MRFR Analysis. The global media sera and reagents- cell culture market is currently dominated by numerous players. Thermo Fisher Scientific, Inc. is one of them by holding a strong share in the market. The company provides analytical instruments, reagents and consumables, software, and services for research, analysis, discovery, manufacturing, and diagnostics under Thermo Scientific, Invitrogen, Fisher Scientific, Applied Biosystems, and Unity Lab Services brands worldwide. On Aug. 29, 2017, Thermo Fisher Scientific Inc. announced the acquisition of Patheon N.V., a leading contract development and manufacturing organization. Browse Full Report @ https://www.marketresearchfuture.com/reports/media-sera-and-reagents-cell-culture-market-1170 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |